NCT00727961 2017-06-08A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)Merck Sharp & Dohme LLCPhase 4 Completed58 enrolled 10 charts